Vericel expands MACI capacity and secures BARDA Burn Care contract

Verifying
  • Vericel is expanding Burlington capacity for its MACI product.
  • MACI repairs cartilage defects, while the company secured a BARDA Burn Care contract.
  • Vericel is advancing its regenerative-medicine operations as demand rises.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.